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Background
MMR vaccination is complicated by rare cases of auto-
immune purpura or thrombocytopenia in a chronologi-
cal delay of about 10-24 days, which corresponds to the
rise of antibodies (Autret E, 1996; Vlacha V, 1996). We
have demonstrated that in the cases of HIV-1, Parvo-
virus B19, Chikungunya virus, Leptospirosis, the culprit
is an epitope localized on the platelet gpIIIaIIb, centred
by a phenylalanine-proline (Tran MKG, ISHEID Toulon
2002); these auto-antibodies are very powerful and
induce in mice a thrombocytopenia; allo-immunisation
from mother to the newborn has the same epitope on
gpIIIaIIb (Brouk H, 2009). We continue the same direc-
tion of research for MMR vaccine.
Methods
Comparison of amino acid sequences between gpIIIaIIb
and viruses (measles, mumps and rubella).
Results
There is a molecular mimicry between gpIIb (P08514)
and measles virus (strain MVi/Victoria.Aus/12.99) Phos-
phoprotein P (ABV24494) (Bankamp B, 2008), Table 1.
Discussion
The occurrence of thrombocytopenia 2 or 3 weeks after
MMR vaccination is an auto-immune phenomenon, on a
peculiar genetic background prone to make auto-antibo-
dies against phenylalanine-proline containing epitopes.
MMR vaccine must be avoided in these patients with
idiopathic thrombocytopenia (Drachtman RA, 1994). The
chronological argument is by itself convincing and con-
firmed here by the biological finding of the causal epitope
on platelet. Thus we must be very cautious in presence of
a MMR vaccine clinical auto-immune complication (such
as autism) (Wakefield AJ) and not discard it as a simple
coincidence, but rather try to elucidate its mechanism
and genetics (HLA-DR4). The gpIIIaIIb epitope may
serve as a chelating hapten for treatment.
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Tabele 1
platelet gpIIb 782 RGNSFP
Measles virus P protein 199-RGNSFP-204
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